ArticlePharmaceutical research2025

Preclinical Prediction of Resistance Mutations and Proposal of Sequential Treatment Strategies for ALK-positive Lung Cancer Using Next-generation ALK Inhibitors.

Yuki Takei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.